NIRx Medical Technologies Email Format
Biotechnology ResearchFlorida, United States51-200 Employees
NIRx Medical Technologies, LLC operates in the biotechnology research industry, focusing on functional near-infrared spectroscopy (fNIRS) research solutions. The company provides non-invasive, user-friendly fNIRS hardware and software, including a versatile multimodal hardware platform, online and offline analysis software, technical and scientific support, and training programs to support neural measurements in the cortex and large-scale cortical networks. Headquartered in Orlando, Florida, the company maintains offices in Orlando and Berlin, Germany, and employs between 51 and 200 people. NIRx operates the NIRx Learning Center, a free resource for fNIRS support and training available at help.nirx.de. Recent developments include the launch of Satori 2.0 in February 2026, the April 2025 release of NIRxWINGS2, a July 2025 partnership with Artinis Medical Systems, and the acquisition of NIRx by Gilde Healthcare Partners BV in September 2025.